+1 (704) 266-3234

Global And United States Viral Vaccines Market Report & Forecast 2022-2028

Published on: May 2022 | From USD $2900 | Published By: QY RESEARCH | Number Of Pages: 106

Viral Vaccines market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Viral Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Viral Vaccines market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Attenuated Vaccine
Inactivated Vaccine
Segment by Application
Hospital
Pharmaceutical Factory
Research Institute
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
GSK
Merck
Novartis
Pfizer
Sanofi
Bayer
Zoetis
AstraZeneca
Johnson
CSL

1 Study Coverage
1.1 Viral Vaccines Product Introduction
1.2 Global Viral Vaccines Outlook 2017 VS 2022 VS 2028
1.2.1 Global Viral Vaccines Sales in US$ Million for the Year 2017-2028
1.2.2 Global Viral Vaccines Sales in Volume for the Year 2017-2028
1.3 United States Viral Vaccines Outlook 2017 VS 2022 VS 2028
1.3.1 United States Viral Vaccines Sales in US$ Million for the Year 2017-2028
1.3.2 United States Viral Vaccines Sales in Volume for the Year 2017-2028
1.4 Viral Vaccines Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Viral Vaccines in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Viral Vaccines Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Viral Vaccines Market Dynamics
1.5.1 Viral Vaccines Industry Trends
1.5.2 Viral Vaccines Market Drivers
1.5.3 Viral Vaccines Market Challenges
1.5.4 Viral Vaccines Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Viral Vaccines Market Segment by Type
2.1.1 Attenuated Vaccine
2.1.2 Inactivated Vaccine
2.2 Global Viral Vaccines Market Size by Type
2.2.1 Global Viral Vaccines Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Viral Vaccines Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Viral Vaccines Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Viral Vaccines Market Size by Type
2.3.1 United States Viral Vaccines Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Viral Vaccines Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Viral Vaccines Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Viral Vaccines Market Segment by Application
3.1.1 Hospital
3.1.2 Pharmaceutical Factory
3.1.3 Research Institute
3.1.4 Others
3.2 Global Viral Vaccines Market Size by Application
3.2.1 Global Viral Vaccines Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Viral Vaccines Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Viral Vaccines Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Viral Vaccines Market Size by Application
3.3.1 United States Viral Vaccines Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Viral Vaccines Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Viral Vaccines Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Viral Vaccines Competitor Landscape by Company
4.1 Global Viral Vaccines Market Size by Company
4.1.1 Top Global Viral Vaccines Manufacturers Ranked by Revenue (2021)
4.1.2 Global Viral Vaccines Revenue by Manufacturer (2017-2022)
4.1.3 Global Viral Vaccines Sales by Manufacturer (2017-2022)
4.1.4 Global Viral Vaccines Price by Manufacturer (2017-2022)
4.2 Global Viral Vaccines Concentration Ratio (CR)
4.2.1 Viral Vaccines Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Viral Vaccines in 2021
4.2.3 Global Viral Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Viral Vaccines Manufacturing Base Distribution, Product Type
4.3.1 Global Viral Vaccines Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Viral Vaccines Product Type
4.3.3 Date of International Manufacturers Enter into Viral Vaccines Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Viral Vaccines Market Size by Company
4.5.1 Top Viral Vaccines Players in United States, Ranked by Revenue (2021)
4.5.2 United States Viral Vaccines Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Viral Vaccines Sales by Players (2020, 2021 & 2022)
5 Global Viral Vaccines Market Size by Region
5.1 Global Viral Vaccines Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Viral Vaccines Market Size in Volume by Region (2017-2028)
5.2.1 Global Viral Vaccines Sales in Volume by Region: 2017-2022
5.2.2 Global Viral Vaccines Sales in Volume Forecast by Region (2023-2028)
5.3 Global Viral Vaccines Market Size in Value by Region (2017-2028)
5.3.1 Global Viral Vaccines Sales in Value by Region: 2017-2022
5.3.2 Global Viral Vaccines Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Viral Vaccines Market Size YoY Growth 2017-2028
6.1.2 North America Viral Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Viral Vaccines Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Viral Vaccines Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Viral Vaccines Market Size YoY Growth 2017-2028
6.3.2 Europe Viral Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Viral Vaccines Market Size YoY Growth 2017-2028
6.4.2 Latin America Viral Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Viral Vaccines Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Viral Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 GSK
7.1.1 GSK Corporation Information
7.1.2 GSK Description and Business Overview
7.1.3 GSK Viral Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.1.4 GSK Viral Vaccines Products Offered
7.1.5 GSK Recent Development
7.2 Merck
7.2.1 Merck Corporation Information
7.2.2 Merck Description and Business Overview
7.2.3 Merck Viral Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Merck Viral Vaccines Products Offered
7.2.5 Merck Recent Development
7.3 Novartis
7.3.1 Novartis Corporation Information
7.3.2 Novartis Description and Business Overview
7.3.3 Novartis Viral Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Novartis Viral Vaccines Products Offered
7.3.5 Novartis Recent Development
7.4 Pfizer
7.4.1 Pfizer Corporation Information
7.4.2 Pfizer Description and Business Overview
7.4.3 Pfizer Viral Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Pfizer Viral Vaccines Products Offered
7.4.5 Pfizer Recent Development
7.5 Sanofi
7.5.1 Sanofi Corporation Information
7.5.2 Sanofi Description and Business Overview
7.5.3 Sanofi Viral Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Sanofi Viral Vaccines Products Offered
7.5.5 Sanofi Recent Development
7.6 Bayer
7.6.1 Bayer Corporation Information
7.6.2 Bayer Description and Business Overview
7.6.3 Bayer Viral Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Bayer Viral Vaccines Products Offered
7.6.5 Bayer Recent Development
7.7 Zoetis
7.7.1 Zoetis Corporation Information
7.7.2 Zoetis Description and Business Overview
7.7.3 Zoetis Viral Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Zoetis Viral Vaccines Products Offered
7.7.5 Zoetis Recent Development
7.8 AstraZeneca
7.8.1 AstraZeneca Corporation Information
7.8.2 AstraZeneca Description and Business Overview
7.8.3 AstraZeneca Viral Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.8.4 AstraZeneca Viral Vaccines Products Offered
7.8.5 AstraZeneca Recent Development
7.9 Johnson
7.9.1 Johnson Corporation Information
7.9.2 Johnson Description and Business Overview
7.9.3 Johnson Viral Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Johnson Viral Vaccines Products Offered
7.9.5 Johnson Recent Development
7.10 CSL
7.10.1 CSL Corporation Information
7.10.2 CSL Description and Business Overview
7.10.3 CSL Viral Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.10.4 CSL Viral Vaccines Products Offered
7.10.5 CSL Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Viral Vaccines Industry Chain Analysis
8.2 Viral Vaccines Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Viral Vaccines Distributors
8.3 Viral Vaccines Production Mode & Process
8.4 Viral Vaccines Sales and Marketing
8.4.1 Viral Vaccines Sales Channels
8.4.2 Viral Vaccines Distributors
8.5 Viral Vaccines Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

List of Tables
Table 1. Viral Vaccines CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Viral Vaccines Market Trends
Table 3. Viral Vaccines Market Drivers
Table 4. Viral Vaccines Market Challenges
Table 5. Viral Vaccines Market Restraints
Table 6. Global Viral Vaccines Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Viral Vaccines Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Viral Vaccines Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Viral Vaccines Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Viral Vaccines Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Viral Vaccines Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Viral Vaccines Revenue Share by Manufacturer, 2017-2022
Table 13. Global Viral Vaccines Sales by Manufacturer, (K MT), 2017-2022
Table 14. Global Viral Vaccines Sales Share by Manufacturer, 2017-2022
Table 15. Global Viral Vaccines Price by Manufacturer (2017-2022) & (USD/MT)
Table 16. Global Viral Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Viral Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vaccines as of 2021)
Table 18. Top Players of Viral Vaccines in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Viral Vaccines Product Type
Table 20. Date of International Manufacturers Enter into Viral Vaccines Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Viral Vaccines Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Viral Vaccines Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Viral Vaccines Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Viral Vaccines Sales by Players, (K MT), 2020, 2021 & 2022
Table 26. United States Viral Vaccines Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Viral Vaccines Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Viral Vaccines Sales in Volume by Region (2017-2022) & (K MT)
Table 29. Global Viral Vaccines Sales in Volume Forecast by Region (2023-2028) & (K MT)
Table 30. Global Viral Vaccines Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Viral Vaccines Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Viral Vaccines Sales in Volume by Country (2017-2028) & (K MT)
Table 33. North America Viral Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Viral Vaccines Sales in Volume by Region (2017-2028) & (K MT)
Table 35. Asia Pacific Viral Vaccines Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Viral Vaccines Sales in Volume by Country (2017-2028) & (K MT)
Table 37. Europe Viral Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Viral Vaccines Sales in Volume by Country (2017-2028) & (K MT)
Table 39. Latin Americaa Viral Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Viral Vaccines Sales in Volume by Country (2017-2028) & (K MT)
Table 41. Middle East and Africa Viral Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. GSK Corporation Information
Table 43. GSK Description and Business Overview
Table 44. GSK Viral Vaccines Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 45. GSK Viral Vaccines Product
Table 46. GSK Recent Development
Table 47. Merck Corporation Information
Table 48. Merck Description and Business Overview
Table 49. Merck Viral Vaccines Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 50. Merck Product
Table 51. Merck Recent Development
Table 52. Novartis Corporation Information
Table 53. Novartis Description and Business Overview
Table 54. Novartis Viral Vaccines Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 55. Novartis Product
Table 56. Novartis Recent Development
Table 57. Pfizer Corporation Information
Table 58. Pfizer Description and Business Overview
Table 59. Pfizer Viral Vaccines Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 60. Pfizer Product
Table 61. Pfizer Recent Development
Table 62. Sanofi Corporation Information
Table 63. Sanofi Description and Business Overview
Table 64. Sanofi Viral Vaccines Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 65. Sanofi Product
Table 66. Sanofi Recent Development
Table 67. Bayer Corporation Information
Table 68. Bayer Description and Business Overview
Table 69. Bayer Viral Vaccines Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 70. Bayer Product
Table 71. Bayer Recent Development
Table 72. Zoetis Corporation Information
Table 73. Zoetis Description and Business Overview
Table 74. Zoetis Viral Vaccines Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 75. Zoetis Product
Table 76. Zoetis Recent Development
Table 77. AstraZeneca Corporation Information
Table 78. AstraZeneca Description and Business Overview
Table 79. AstraZeneca Viral Vaccines Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 80. AstraZeneca Product
Table 81. AstraZeneca Recent Development
Table 82. Johnson Corporation Information
Table 83. Johnson Description and Business Overview
Table 84. Johnson Viral Vaccines Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 85. Johnson Product
Table 86. Johnson Recent Development
Table 87. CSL Corporation Information
Table 88. CSL Description and Business Overview
Table 89. CSL Viral Vaccines Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 90. CSL Product
Table 91. CSL Recent Development
Table 92. Key Raw Materials Lists
Table 93. Raw Materials Key Suppliers Lists
Table 94. Viral Vaccines Customers List
Table 95. Viral Vaccines Distributors List
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Viral Vaccines Product Picture
Figure 2. Global Viral Vaccines Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Viral Vaccines Market Size 2017-2028 (US$ Million)
Figure 4. Global Viral Vaccines Sales 2017-2028 (K MT)
Figure 5. United States Viral Vaccines Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Viral Vaccines Market Size 2017-2028 (US$ Million)
Figure 7. United States Viral Vaccines Sales 2017-2028 (K MT)
Figure 8. United States Viral Vaccines Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Viral Vaccines Market Share in Global, in Volume (K MT) 2017-2028
Figure 10. Viral Vaccines Report Years Considered
Figure 11. Product Picture of Attenuated Vaccine
Figure 12. Product Picture of Inactivated Vaccine
Figure 13. Global Viral Vaccines Market Share by Type in 2022 & 2028
Figure 14. Global Viral Vaccines Sales in Value by Type (2017-2028) & (US$ Million)
Figure 15. Global Viral Vaccines Sales Market Share in Value by Type (2017-2028)
Figure 16. Global Viral Vaccines Sales by Type (2017-2028) & (K MT)
Figure 17. Global Viral Vaccines Sales Market Share in Volume by Type (2017-2028)
Figure 18. Global Viral Vaccines Price by Type (2017-2028) & (USD/MT)
Figure 19. United States Viral Vaccines Market Share by Type in 2022 & 2028
Figure 20. United States Viral Vaccines Sales in Value by Type (2017-2028) & (US$ Million)
Figure 21. United States Viral Vaccines Sales Market Share in Value by Type (2017-2028)
Figure 22. United States Viral Vaccines Sales by Type (2017-2028) & (K MT)
Figure 23. United States Viral Vaccines Sales Market Share in Volume by Type (2017-2028)
Figure 24. United States Viral Vaccines Price by Type (2017-2028) & (USD/MT)
Figure 25. Product Picture of Hospital
Figure 26. Product Picture of Pharmaceutical Factory
Figure 27. Product Picture of Research Institute
Figure 28. Product Picture of Others
Figure 29. Global Viral Vaccines Market Share by Application in 2022 & 2028
Figure 30. Global Viral Vaccines Sales in Value by Application (2017-2028) & (US$ Million)
Figure 31. Global Viral Vaccines Sales Market Share in Value by Application (2017-2028)
Figure 32. Global Viral Vaccines Sales by Application (2017-2028) & (K MT)
Figure 33. Global Viral Vaccines Sales Market Share in Volume by Application (2017-2028)
Figure 34. Global Viral Vaccines Price by Application (2017-2028) & (USD/MT)
Figure 35. United States Viral Vaccines Market Share by Application in 2022 & 2028
Figure 36. United States Viral Vaccines Sales in Value by Application (2017-2028) & (US$ Million)
Figure 37. United States Viral Vaccines Sales Market Share in Value by Application (2017-2028)
Figure 38. United States Viral Vaccines Sales by Application (2017-2028) & (K MT)
Figure 39. United States Viral Vaccines Sales Market Share in Volume by Application (2017-2028)
Figure 40. United States Viral Vaccines Price by Application (2017-2028) & (USD/MT)
Figure 41. North America Viral Vaccines Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 42. North America Viral Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 43. U.S. Viral Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 44. Canada Viral Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 45. Europe Viral Vaccines Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 46. Europe Viral Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 47. Germany Viral Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. France Viral Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. U.K. Viral Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Italy Viral Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Russia Viral Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Asia-Pacific Viral Vaccines Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 53. Asia-Pacific Viral Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 54. China Viral Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. Japan Viral Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. South Korea Viral Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. India Viral Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Australia Viral Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Taiwan Viral Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Indonesia Viral Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Thailand Viral Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Malaysia Viral Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Philippines Viral Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Latin America Viral Vaccines Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 65. Latin America Viral Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 66. Mexico Viral Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Brazil Viral Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Argentina Viral Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Middle East & Africa Viral Vaccines Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 70. Middle East & Africa Viral Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 71. Turkey Viral Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. Saudi Arabia Viral Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. UAE Viral Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. Viral Vaccines Value Chain
Figure 75. Viral Vaccines Production Process
Figure 76. Channels of Distribution
Figure 77. Distributors Profiles
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $2900
USD $3900
USD $4900
COVID-19
Offer

WHY US?

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Why Us Customer Support
    Complete pre and post sales support.
  • Why Us Safe & Secure
    Complete secure payment process.